Position in ANIK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,423,740
+$1,176,846 QoQ
Shares Held
236,120
+1.0% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $750,878,580 across 46 Drug Manufacturers - Specialty & Generic names. ANIK ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,060,570 | $403,199,491 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,392,628 | $60,857,818 | |
| 3 | ALKS |
Alkermes plc.
|
780,683 | $27,604,950 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
9,458,779 | $25,917,054 | |
| 5 | LQDA |
Liquidia Corp
|
563,233 | $21,256,413 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
5,848,276 | $20,527,448 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
420,914 | $20,267,009 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
590,116 | $19,515,136 |
All Filings in ANIK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,423,740 | 236,120 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,246,894 | 233,808 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $751,257 | 79,921 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $199,100 | 12,096 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $526,999 | 21,336 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $711,773 | 28,100 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,200,658 | 47,270 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,365,582 | 60,264 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $328,148 | 17,614 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,677,009 | 64,550 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,390,191 | 48,405 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,853,907 | 62,632 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $779,521 | 32,753 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,458,969 | 65,366 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,212,235 | 48,277 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,922,458 | 53,655 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,790,574 | 65,568 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,018,393 | 115,925 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,600,418 | 112,783 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,364,110 | 52,234 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,597,929 | 45,152 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,038,857 | 27,534 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $811,850 | 28,082 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||